|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 HKD | 0.00% |
|
+2.56% | -15.49% |
| 25/03 | Zhongzhi Pharmaceutical's Attributable Jumps in 2023 | MT |
| 22/03 | Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024 | CI |
Zhongzhi Pharmaceutical Holdings Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 846.4 million compared to CNY 886.72 million a year ago. Net income was CNY 77.05 million compared to CNY 66.59 million a year ago.
Basic earnings per share from continuing operations was CNY 0.091 compared to CNY 0.081 a year ago. Diluted earnings per share from continuing operations was CNY 0.091 compared to CNY 0.081 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.49% | 13Cr | |
| +20.27% | 4.39TCr | |
| +24.56% | 2.31TCr | |
| +20.07% | 1.53TCr | |
| +13.31% | 1.36TCr | |
| +46.26% | 1.2TCr | |
| -10.14% | 699.72Cr | |
| -0.05% | 678.76Cr | |
| -8.87% | 572.55Cr | |
| +13.07% | 559.68Cr |
ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED 
